Drug
Dexamethasone clinical trials
Also written Decadron, Hexadrol, Hexadecadrol and ISV-305.
Includes 65 studies of Dexamethasone phosphate, 12 studies of Dexamethasone acetate and 6 studies of Dexamethasone palmitate.
- studies test it
- 1,888
- open now
- 285
- in phase 3
- 327
- first study started
- 1990
Keep track of what changes. Save the Dexamethasone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Dexamethasone
- 1,267
- Dexameth
- 79
- Adexone
- 74
- Decadrol
- 74
Brand
Other names
Combined with it in one product
- Ozurdex
- 16
Studies by the year they started
1,879 studies that test it; most in 2021 (126); 3 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1992 | 1 |
| 1993 | 2 |
| 1995 | 5 |
| 1996 | 5 |
| 1997 | 3 |
| 1998 | 10 |
| 1999 | 5 |
| 2000 | 15 |
| 2001 | 9 |
| 2002 | 26 |
| 2003 | 23 |
| 2004 | 28 |
| 2005 | 37 |
| 2006 | 46 |
| 2007 | 46 |
| 2008 | 59 |
| 2009 | 49 |
| 2010 | 62 |
| 2011 | 59 |
| 2012 | 71 |
| 2013 | 77 |
| 2014 | 88 |
| 2015 | 99 |
| 2016 | 107 |
| 2017 | 104 |
| 2018 | 107 |
| 2019 | 82 |
| 2020 | 109 |
| 2021 | 126 |
| 2022 | 81 |
| 2023 | 78 |
| 2024 | 86 |
| 2025 | 82 |
| 2026 | 91 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 33
- Phase 1
- 307
- Phase 2
- 715
- Phase 3
- 327
- Phase 4
- 433
- No phase
- 254
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 254 · Other 1,634
Assiut University (40) · Mayo Clinic (38) · M.D. Anderson Cancer Center (37) · National Cancer Institute (NCI) (23) · Memorial Sloan Kettering Cancer Center (23) · Poznan University of Medical Sciences (23) · Ain Shams University (21) · Celgene (18)
Often tested with
Tested in the same studies.
Lenalidomide (199) · Bortezomib (171) · Cyclophosphamide (140) · Pomalidomide (94) · Carfilzomib (86) · Doxorubicin (74) · Vincristine (73) · Daratumumab (72)
Studies
Open first, then newest update. How each study uses Dexamethasone is read from its arms, and is right about nine times in ten.
Testing it · 1,888
- ESP Blocks in Breast Free FlapsRecruitingPhase 1Carilion ClinicNCT07891039Written as Bupivacaine with Epinephrine and Dexamethasone
- Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis SurgeryNot yet recruitingPhase 4Poznan University of Medical SciencesNCT07890220Written as Dexamethasone (0.1 mg/kg)
- Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT04891289Written as Dexamethasone
- A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaRecruitingPhase 1K36 Therapeutics, Inc.NCT05651932Written as Cohort A1 & A2: KTX-1001
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)RecruitingPhase 1/2AbbVieNCT06953960Written as Dexamethasone
- Exparel and DexamethasoneNot yet recruitingPhase 4Duke UniversityNCT07614802Written as Dexamethasone
- Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab DeruxtecanNot yet recruitingPhase 3Mario Negri Institute for Pharmacological ResearchNCT07828054Written as Dexamethasone
- A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in CombinationsRecruitingPhase 1/2AbbVieNCT06892522Written as Dexamethasone
- A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantRecruitingPhase 2/3AbbVieNCT07095452Written as Dexamethasone
- Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like PatientsRecruitingPhase 2The First Affiliated Hospital of Soochow UniversityNCT07159620Written as Dexamethasone
- Low-Volume Pericapsular Nerve Group (PENG) Block With Dexamethasone vs Standard-Volume PENG Block After Total Hip ArthroplastyRecruitingPhase 4Ain Shams UniversityNCT07855341Written as Dexamethasone
- Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationRecruitingNot applicableChina National Center for Cardiovascular DiseasesNCT07877519Written as Dexamethasone
- Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple MyelomaRecruitingPhase 2Hoffmann-La RocheNCT07825064Written as Dexamethasone
- Isatuximab in Combination With Novel Agents in RRMM - Master ProtocolRecruitingPhase 1/2SanofiNCT04643002Written as Dexamethasone
- Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility StudyRecruitingPhase 2Lorenzo delSorboNCT07334379Written as Dexamethasone
- Impact of Intravenous Dexamethasone on the Duration of Motor and Sensory Block Following Spinal Anesthesia With ChloroprocaineNot yet recruitingNot applicableCentre hospitalier de l'Université de Montréal (CHUM)NCT07837674Written as Intravenous Dexamethasone
- A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT05319730Written as Dexamethasone (or equivalent)
- Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMMRecruitingPhase 1/2Omar Nadeem, MDNCT06518551Written as Dexamethasone
- A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple MyelomaRecruitingPhase 1/2Hoffmann-La RocheNCT05583617Written as Dexamethasone
- Prevent Wheeze TrialNot yet recruitingPhase 4Norwegian University of Science and TechnologyNCT07858773Written as Dexamethasone 0.6 mg/kilogram body weight single dose
See all 1,888 studies that test Dexamethasone →
Given in every arm · 777 — Dexamethasone is usual care beside what is tested
- Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple MyelomaNot yet recruitingPhase 2/3Alliance for Clinical Trials in OncologyNCT07887984Written as Dexamethasone
- A Trial to Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Standard of Care in Newly Diagnosed Multiple MyelomaNot yet recruitingPhase 3Kite, A Gilead CompanyNCT07887672Written as Dexamethasone
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as Dexamethasone
- Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06353386Written as Dexamethasone
- A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)RecruitingPhase 3Regeneron PharmaceuticalsNCT07222761Written as Dexamethasone
- A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple MyelomaRecruitingPhase 1Genentech, Inc.NCT04910568Written as Dexamethasone
- Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering MyelomaRecruitingPhase 2University College, LondonNCT06762769Written as Dexamethasone
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06136650Written as Dexamethasone
- Modified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine SurgeriesRecruitingNot applicableZagazig UniversityNCT07883616Written as Dexamethasone
- Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaRecruitingPhase 3Alliance for Clinical Trials in OncologyNCT03150693Written as Dexamethasone
- A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT07570173Written as Dexamethasone
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaRecruitingPhase 2National Cancer Institute (NCI)NCT05286814Written as Dexamethasone
- International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From IsatuximabEnrolling by invitationPhase 2SanofiNCT05669989Written as Dexamethasone
- Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)RecruitingPhase 1/2Novartis PharmaceuticalsNCT07387926Written as Dexamethasone
- A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)RecruitingPhase 2Merck Sharp & Dohme LLCNCT07785609Written as Dexamethasone (or equivalent)
- Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple MyelomaRecruitingPhase 3Canadian Cancer Trials GroupNCT06182774Written as Dexamethasone
- Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More TreatmentNot yet recruitingPhase 2SWOG Cancer Research NetworkNCT07636564Written as Dexamethasone
- Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric AdenotonsillectomyNot yet recruitingPhase 1/2NYU Langone HealthNCT07870447Written as Dexamethasone
- A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)Not yet recruitingPhase 1Merck Sharp & Dohme LLCNCT07870278Written as Dexamethasone
- Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingPhase 2City of Hope Medical CenterNCT06918431Written as Dexamethasone
Showing 20 of 777.
As the comparator · 143 — what is tested is compared with Dexamethasone
- Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First RelapseRecruitingPhase 2National Cancer Institute (NCI)NCT06948084Written as Dexamethasone
- Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After TreatmentRecruitingPhase 1/2National Cancer Institute (NCI)NCT07463807Written as Dexamethasone
- D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMMRecruitingPhase 3Dana-Farber Cancer InstituteNCT07624513Written as Dexamethasone
- A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple MyelomaRecruitingPhase 3Regeneron PharmaceuticalsNCT05730036Written as Dexamethasone
- A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedRecruitingPhase 3Janssen Research & Development, LLCNCT07665450Written as Dexamethasone
- Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNot yet recruitingPhase 2/3ECOG-ACRIN Cancer Research GroupNCT07852195Written as Dexamethasone
- A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)RecruitingPhase 3AstraZenecaNCT07391657Written as Dexamethasone
- A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantRecruitingPhase 3PfizerNCT05623020Written as Dexamethasone
- A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaRecruitingPhase 3Janssen Research & Development, LLCNCT05552222Written as Dexamethasone
- Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2Not yet recruitingPhase 3Semnur Pharmaceuticals, Inc.NCT07579351Written as Dexamethasone Sodium Phosphate 10 MG/ML
- Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic CholecystectomyRecruitingPhase 4Faisalabad Medical UniversityNCT07638527Written as Dexamethasone (intravenous)
- Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) AmyloidosisNot yet recruitingPhase 3AbbVieNCT07793422Written as Dexamethasone
- A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsRecruitingPhase 3PfizerNCT05020236Written as Dexamethasone
- MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)RecruitingPhase 3PfizerNCT06152575Written as Dexamethasone
- Magnesium Sulphate Versus Dexamethasone With TAP Block for Post-Cesarean AnalgesiaNot yet recruitingNot applicableKhyber Teaching HospitalNCT07773220Written as Dexamethasone
- A Open-Label Phase in Participants With Multiple MyelomaNot yet recruitingPhase 2Innovent Biologics (Suzhou) Co. Ltd.NCT07764861Written as Dexamethasone
- Evaluation of Iopofosine I 131 vs. R-CD in WM PatientsNot yet recruitingPhase 3Cellectar Biosciences, Inc.NCT07766421Written as Dexamethasone
- Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk FactorsRecruitingNot applicableAlexandria UniversityNCT07743827Written as Dexamethasone
- A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)RecruitingPhase 3BiocadNCT07742215Written as Daratumumab + pomalidomide + dexamethasone
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple MyelomaNot yet recruitingPhase 3AbbVieNCT07728188Written as Dexamethasone
Showing 20 of 143.
Codes
What other systems call Dexamethasone · ClinicalTrials.gg INT007323
- MeSH (NLM) D003907DexamethasoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7S5I7G3JQLDEXAMETHASONEConfirmed FDA, NLM, Wikidata
- RxNorm 3264Confirmed FDA, Wikidata
- Wikidata Q422252dexamethasoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C422DexamethasoneOne source FDA
- DrugBank DB01234One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003907 | Dexamethasone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7S5I7G3JQL | DEXAMETHASONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3264 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422252 | dexamethasone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C422 | Dexamethasone | One source FDA |
| DrugBank | DB01234 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.